edoc

Items where Author is "Linkesch, Werner"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2015 | 2011 | 2009
Number of items: 3.

2015

Cerny-Reiterer, Sabine and Rabenhorst, Anja and Stefanzl, Gabriele and Herndlhofer, Susanne and Hoermann, Gregor and Müllauer, Leonhard and Baumgartner, Sigrid and Beham-Schmid, Christine and Sperr, Wolfgang R. and Mannhalter, Christine and Sill, Heinz and Linkesch, Werner and Arock, Michel and Hartmann, Karin and Valent, Peter. (2015) Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia. Oncotarget, 6 (5). pp. 3071-3084.

2011

Socié, Gérard and Schmoor, Claudia and Bethge, Wolfgang A. and Ottinger, Hellmut D. and Stelljes, Matthias and Zander, Axel R. and Volin, Liisa and Ruutu, Tapani and Heim, Dominik A. and Schwerdtfeger, Rainer and Kolbe, Karin and Mayer, Jiri and Maertens, Johan A. and Linkesch, Werner and Holler, Ernst and Koza, Vladimir and Bornhäuser, Martin and Einsele, Hermann and Kolb, Hans-Jochem and Bertz, Hartmut and Egger, Matthias and Grishina, Olga and Finke, Jürgen and ATG-Fresenius Trial Group, . (2011) Chronic graft-versus-host disease : long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood, Vol. 117, H. 23. pp. 6375-6382.

2009

Finke, Jürgen and Bethge, Wolfgang A. and Schmoor, Claudia and Ottinger, Hellmut D. and Stelljes, Matthias and Zander, Axel R. and Volin, Liisa and Ruutu, Tapani and Heim, Dominik A. and Schwerdtfeger, Rainer and Kolbe, Karin and Mayer, Jiri and Maertens, Johan A. and Linkesch, Werner and Holler, Ernst and Koza, Vladimir and Bornhäuser, Martin and Einsele, Hermann and Kolb, Hans-Jochem and Bertz, Hartmut and Egger, Matthias and Grishina, Olga and Socié, Gérard. (2009) Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors : a randomised, open-label, multicentre phase 3 trial. The Lancet oncology, Vol. 10. pp. 855-864.

This list was generated on Sun Jul 5 23:26:31 2020 CEST.